Conference · Stevenage, United Kingdom
Biosimilars to Biobetters - the paths forward
Life Sciences · Biochemistry · Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2013
About Biosimilars to Biobetters - the paths forward
Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue, the opportunity for development of competing, follow on biologics remains an attractive proposition for both Biotech and Pharma companies alike. However, as these biosimilar markets are captured how we manage the life cycle of these products and target specific patient and commercial benefits to maximise our product development strategies becomes increasingly important.
This Euroscicon biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place.
Who should attend
Specialists in regulatory strategy and affairs, Biopharmaceutical developers/manufacturers including analytics/characterisation, marketing professionals, product enabling technology development companies
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2013 | 16 May 2013 | The Stevenage Bioscience Catalyst Stevenage, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Biosimilars to Biobetters - the paths forward?
The next dates haven't been confirmed. The last edition we have on record was 16 May 2013.
Where is it held?
The last edition we have was at The Stevenage Bioscience Catalyst, Stevenage, United Kingdom.